G. Pomatico

Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor-receptor antibody on human breast cancer cell growth.

G. Tortora, F. Ciardiello, J. Mendelsohn, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Resistance to taxanes is induced by c‐erbB‐2 overexpression in human MCF‐10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A

G. Tortora, F. Ciardiello, S. de Placido, 2000, International journal of cancer.

Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.

G. Tortora, F. Ciardiello, R. Bianco, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cooperative antitumor effect of mixed backbone oligonucleotides targeting protein kinase A in combination with cytotoxic drugs or biologic agents.

G. Tortora, F. Ciardiello, R. Bianco, 1998, Antisense & nucleic acid drug development.

Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.

G. Fontanini, G. Tortora, F. Ciardiello, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.

G. Tortora, F. Ciardiello, R. Bianco, 1998, Journal of the National Cancer Institute.

Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells.

G. Tortora, F. Ciardiello, R. Bianco, 1997, Cancer research.

Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells.

A. Casamassimi, N. Normanno, G. Tortora, 1999, Oncology reports.

Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an EGFR-selective tyrosine kinase inhibitor.

G. Tortora, F. Ciardiello, R. Bianco, 2000 .